Angion Biomedica Corp Stock Debt To Equity
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
Angion Biomedica Corp fundamentals help investors to digest information that contributes to Angion Biomedica's financial success or failures. It also enables traders to predict the movement of Angion Stock. The fundamental analysis module provides a way to measure Angion Biomedica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Angion Biomedica stock.
Angion |
Angion Biomedica Corp Company Debt To Equity Analysis
Angion Biomedica's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Angion Biomedica Debt To Equity | 0.07 % |
Most of Angion Biomedica's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Angion Biomedica Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Angion Biomedica Corp has a Debt To Equity of 0.07%. This is 99.87% lower than that of the Healthcare sector and 99.64% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 99.86% higher than that of the company.
Angion Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Angion Biomedica's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Angion Biomedica could also be used in its relative valuation, which is a method of valuing Angion Biomedica by comparing valuation metrics of similar companies.Angion Biomedica is currently under evaluation in debt to equity category among its peers.
Angion Fundamentals
| Return On Equity | -0.54 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (31.48) % | |||
| Current Valuation | (26.79 M) | |||
| Shares Outstanding | 30.11 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 16.36 % | |||
| Number Of Shares Shorted | 63.65 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 2.3 M | |||
| Gross Profit | (15.8 M) | |||
| EBITDA | (20.12 M) | |||
| Net Income | (38.81 M) | |||
| Cash And Equivalents | 63.37 M | |||
| Cash Per Share | 2.10 X | |||
| Total Debt | 4.2 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 8.47 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (38.39 M) | |||
| Short Ratio | 0.73 X | |||
| Earnings Per Share | (10.11) X | |||
| Target Price | 1.5 | |||
| Beta | 0.6 | |||
| Market Capitalization | 30.11 M | |||
| Total Asset | 52.79 M | |||
| Retained Earnings | (253.94 M) | |||
| Working Capital | 45.06 M | |||
| Current Asset | 18.1 M | |||
| Current Liabilities | 5.28 M | |||
| Z Score | -2.62 | |||
| Net Asset | 52.79 M |
About Angion Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Angion Biomedica Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Angion Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Angion Biomedica Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Angion Biomedica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angion Biomedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will appreciate offsetting losses from the drop in the long position's value.Moving against Angion Stock
| 0.77 | PPERF | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.76 | SHG | Shinhan Financial | PairCorr |
| 0.74 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.7 | NVO | Novo Nordisk AS | PairCorr |
| 0.7 | NONOF | Novo Nordisk AS | PairCorr |
The ability to find closely correlated positions to Angion Biomedica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angion Biomedica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angion Biomedica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angion Biomedica Corp to buy it.
The correlation of Angion Biomedica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angion Biomedica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |